Interacting Drugs |
Boceprevir vs Maraviroc |
Security Level |
|
Mechanism |
Maraviroc: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Maraviroc. |
Management |
Reduce the adult dose of maraviroc to 150 mg twice daily when used with a strong CYP3A4 inhibitor. Do not use maraviroc with strong CYP3A4 inhibitors in patients with Clcr less than 30 mL/min. |
Boceprevir vs Maraviroc
Post Review about Boceprevir vs Maraviroc Click here to cancel reply.
Other Interactions of Boceprevir
Other Interactions of Maraviroc
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.